RGLS logo

Regulus Therapeutics (RGLS) Operating Profit

Annual Operating Profit

-$31.11 M
-$2.87 M-10.16%

December 31, 2023


Summary


Performance

RGLS Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRGLSprofitabilitymetrics:

Quarterly Operating Profit

-$15.21 M
-$2.95 M-24.06%

September 30, 2024


Summary


Performance

RGLS Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRGLSprofitabilitymetrics:

TTM Operating Profit

-$44.60 M
-$7.08 M-18.89%

September 30, 2024


Summary


Performance

RGLS TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRGLSprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

RGLS Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-10.2%-24.1%-18.9%
3 y3 years-119.8%-112.0%-53.1%
5 y5 years+33.5%-204.6%-209.3%

RGLS Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-11.8%at low-131.5%at low-60.3%at low
5 y5-year-119.8%at low-1378.1%at low-215.1%at low
alltimeall time-335.9%+61.8%-1463.2%+28.9%-4483.4%+45.3%

Regulus Therapeutics Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
-$15.21 M(+24.1%)
-$44.60 M(+18.9%)
Jun 2024
-
-$12.26 M(+38.9%)
-$37.51 M(+15.2%)
Mar 2024
-
-$8.83 M(+6.3%)
-$32.57 M(+4.7%)
Dec 2023
-$31.11 M(+10.2%)
-$8.30 M(+2.2%)
-$31.11 M(+4.6%)
Sep 2023
-
-$8.13 M(+11.1%)
-$29.74 M(+1.9%)
Jun 2023
-
-$7.32 M(-0.7%)
-$29.18 M(+0.5%)
Mar 2023
-
-$7.37 M(+6.3%)
-$29.04 M(+2.8%)
Dec 2022
-$28.24 M(+1.5%)
-$6.93 M(-8.3%)
-$28.24 M(-0.1%)
Sep 2022
-
-$7.56 M(+5.4%)
-$28.27 M(-2.9%)
Jun 2022
-
-$7.17 M(+9.2%)
-$29.12 M(+1.9%)
Mar 2022
-
-$6.57 M(-5.6%)
-$28.59 M(+2.8%)
Dec 2021
-$27.82 M(+96.5%)
-$6.96 M(-17.3%)
-$27.82 M(+27.1%)
Sep 2021
-
-$8.42 M(+26.8%)
-$21.88 M(+50.3%)
Jun 2021
-
-$6.64 M(+14.5%)
-$14.56 M(+1.0%)
Mar 2021
-
-$5.80 M(+463.5%)
-$14.42 M(+1.9%)
Dec 2020
-$14.15 M(-15.9%)
-$1.03 M(-6.0%)
-$14.15 M(-19.4%)
Sep 2020
-
-$1.09 M(-83.1%)
-$17.56 M(-18.2%)
Jun 2020
-
-$6.50 M(+17.4%)
-$21.46 M(+9.3%)
Mar 2020
-
-$5.54 M(+24.8%)
-$19.63 M(+16.6%)
Dec 2019
-$16.83 M(-64.0%)
-$4.43 M(-11.2%)
-$16.83 M(-17.4%)
Sep 2019
-
-$4.99 M(+7.0%)
-$20.38 M(-19.3%)
Jun 2019
-
-$4.67 M(+70.5%)
-$25.24 M(-25.6%)
Mar 2019
-
-$2.74 M(-65.7%)
-$33.92 M(-27.5%)
Dec 2018
-$46.76 M(-33.3%)
-$7.98 M(-19.0%)
-$46.76 M(-10.9%)
Sep 2018
-
-$9.85 M(-26.2%)
-$52.49 M(-9.6%)
Jun 2018
-
-$13.34 M(-14.4%)
-$58.05 M(-12.1%)
Mar 2018
-
-$15.58 M(+13.7%)
-$66.02 M(-5.9%)
DateAnnualQuarterlyTTM
Dec 2017
-$70.13 M(-14.0%)
-$13.71 M(-11.1%)
-$70.13 M(-7.9%)
Sep 2017
-
-$15.41 M(-27.7%)
-$76.17 M(-4.7%)
Jun 2017
-
-$21.32 M(+8.2%)
-$79.94 M(+0.2%)
Mar 2017
-
-$19.69 M(-0.3%)
-$79.82 M(-2.1%)
Dec 2016
-$81.50 M(+48.8%)
-$19.74 M(+2.9%)
-$81.50 M(+17.9%)
Sep 2016
-
-$19.19 M(-9.4%)
-$69.12 M(+9.2%)
Jun 2016
-
-$21.19 M(-0.9%)
-$63.27 M(+0.0%)
Mar 2016
-
-$21.38 M(+190.4%)
-$63.27 M(+15.5%)
Dec 2015
-$54.76 M(+21.9%)
-$7.36 M(-44.8%)
-$54.76 M(-3.8%)
Sep 2015
-
-$13.35 M(-37.0%)
-$56.93 M(+3.1%)
Jun 2015
-
-$21.18 M(+64.6%)
-$55.24 M(+17.4%)
Mar 2015
-
-$12.87 M(+35.0%)
-$47.08 M(+4.8%)
Dec 2014
-$44.91 M(+152.3%)
-$9.53 M(-18.2%)
-$44.91 M(+12.2%)
Sep 2014
-
-$11.66 M(-10.4%)
-$40.04 M(+28.0%)
Jun 2014
-
-$13.01 M(+21.6%)
-$31.29 M(+36.3%)
Mar 2014
-
-$10.71 M(+129.6%)
-$22.96 M(+29.0%)
Dec 2013
-$17.80 M(+41.6%)
-$4.66 M(+60.5%)
-$17.80 M(+2.1%)
Sep 2013
-
-$2.90 M(-38.0%)
-$17.44 M(-3.5%)
Jun 2013
-
-$4.69 M(-15.6%)
-$18.07 M(+13.3%)
Mar 2013
-
-$5.55 M(+29.0%)
-$15.94 M(+26.8%)
Dec 2012
-$12.57 M(+76.2%)
-$4.30 M(+21.8%)
-$12.57 M(+23.9%)
Sep 2012
-
-$3.53 M(+38.1%)
-$10.15 M(+33.7%)
Jun 2012
-
-$2.56 M(+17.3%)
-$7.59 M(+50.9%)
Mar 2012
-
-$2.18 M(+16.2%)
-$5.03 M(+76.5%)
Dec 2011
-$7.14 M(-53.9%)
-$1.88 M(+92.8%)
-$2.85 M(+192.8%)
Sep 2011
-
-$973.00 K
-$973.00 K
Dec 2010
-$15.50 M
-
-

FAQ

  • What is Regulus Therapeutics annual operating income?
  • What is the all time high annual operating profit for Regulus Therapeutics?
  • What is Regulus Therapeutics annual operating profit year-on-year change?
  • What is Regulus Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for Regulus Therapeutics?
  • What is Regulus Therapeutics quarterly operating profit year-on-year change?
  • What is Regulus Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for Regulus Therapeutics?
  • What is Regulus Therapeutics TTM operating profit year-on-year change?

What is Regulus Therapeutics annual operating income?

The current annual operating profit of RGLS is -$31.11 M

What is the all time high annual operating profit for Regulus Therapeutics?

Regulus Therapeutics all-time high annual operating income is -$7.14 M

What is Regulus Therapeutics annual operating profit year-on-year change?

Over the past year, RGLS annual operating income has changed by -$2.87 M (-10.16%)

What is Regulus Therapeutics quarterly operating income?

The current quarterly operating profit of RGLS is -$15.21 M

What is the all time high quarterly operating profit for Regulus Therapeutics?

Regulus Therapeutics all-time high quarterly operating income is -$973.00 K

What is Regulus Therapeutics quarterly operating profit year-on-year change?

Over the past year, RGLS quarterly operating income has changed by -$2.95 M (-24.06%)

What is Regulus Therapeutics TTM operating income?

The current TTM operating profit of RGLS is -$44.60 M

What is the all time high TTM operating profit for Regulus Therapeutics?

Regulus Therapeutics all-time high TTM operating income is -$973.00 K

What is Regulus Therapeutics TTM operating profit year-on-year change?

Over the past year, RGLS TTM operating income has changed by -$7.08 M (-18.89%)